Category Archives: Uncategorized

Evaluating the Ability to Consent to Research: A Twenty-Year Track Record

Posted on by

Ethics & Human Research
Volume 44, Issue 2 Pages: 1-40 March–April 2022
https://onlinelibrary.wiley.com/toc/25782363/current

 

Articles
Evaluating the Ability to Consent to Research: A Twenty-Year Track Record
Mikaela Matera-Vatnick, Katherine W. Todman, Paul G. Wakim, Haley K. Sullivan, Carol Squires, Julie Brintnall-Karabelas, Samuel N. Doernberg, Marion Danis
Pages: 2-17
First Published: 26 February 2022

Alternative provision of public health care: the role of citizens’ satisfaction with public services and the social responsibility of government

Posted on by

Health Economics, Policy and Law 
Volume 17 – Issue 2 – April 2022
https://www.cambridge.org/core/journals/health-economics-policy-and-law/latest-issue

 

Article
Alternative provision of public health care: the role of citizens’ satisfaction with public services and the social responsibility of government
Nissim Cohen, Shlomo Mizrahi, Eran Vigoda-Gadot
Published online by Cambridge University Press: 20 July 2020, pp. 121-140

Priority setting and equity in COVID-19 pandemic plans: a comparative analysis of 18 African countries

Posted on by

Health Policy and Planning
Volume 37, Issue 3, March 2022
https://academic.oup.com/heapol/issue/37/3

 

ORIGINAL ARTICLES
Priority setting and equity in COVID-19 pandemic plans: a comparative analysis of 18 African countries
Lydia Kapiriri, Suzanne Kiwanuka, Godfrey Biemba, Claudia Velez, S Donya Razavi …
Health Policy and Planning, Volume 37, Issue 3, March 2022, Pages 297–309, https://doi.org/10.1093/heapol/czab113

Meanings and mechanisms of One Health partnerships: insights from a critical review of literature on cross-government collaborations

Posted on by

Health Policy and Planning
Volume 37, Issue 3, March 2022
https://academic.oup.com/heapol/issue/37/3

 

REVIEWS
Meanings and mechanisms of One Health partnerships: insights from a critical review of literature on cross-government collaborations
Syed Shahid Abbas, Tim Shorten, Jonathan Rushton
Health Policy and Planning, Volume 37, Issue 3, March 2022, Pages 385–399, https://doi.org/10.1093/heapol/czab134

Rapid method through routine data to evaluate real-world vaccine effectiveness against coronavirus disease 2019 (COVID-19) infection: lessons from Thailand

Posted on by

Health Research Policy and Systems
http://www.health-policy-systems.com/content
[Accessed 12 Mar 2022]

 

Rapid method through routine data to evaluate real-world vaccine effectiveness against coronavirus disease 2019 (COVID-19) infection: lessons from Thailand
The objective of this article is to draw lessons from the Thai experience in estimating vaccine effectiveness (VE) for coronavirus disease 2019 (COVID-19) based on routine service data. We found that a matched…
Authors: Natthaprang Nittayasoot, Panithee Thammawijaya, Piyanit Tharmaphornpilas, Chalo Sansilapin, Chuleeporn Jiraphongsa and Rapeepong Suphanchaimat
Citation: Health Research Policy and Systems 2022 20:29

Single-cell immunology: Past, present, and future

Posted on by

Immunity
Mar 08, 2022 Volume 55 Issue 3 p377-574
https://www.cell.com/immunity/current

 

Perspective
Single-cell immunology: Past, present, and future
Florent Ginhoux, Adam Yalin, Charles Antoine Dutertre, Ido Amit
In this perspective, Ginhoux, Yalin, Dutertre, and Amit outline the past, present, and future applications of single-cell genomics in immunology and discuss how the integration of multiomics at the single-cell level will pave the way for future advances in immunology research and clinical translation.

Long-Acting Cabotegravir for HIV PreventionIssues of Access, Cost, and Equity

Posted on by

JAMA
March 8, 2022, Vol 327, No. 10, Pages 897-1003
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Long-Acting Cabotegravir for HIV PreventionIssues of Access, Cost, and Equity
Joshua M. Sharfstein, MD; Amy Killelea, JD; Derek Dangerfield, PhD
free access
JAMA. 2022;327(10):921-922. doi:10.1001/jama.2022.0420
This Viewpoint discusses the recent FDA approval of cabotegravir, the first injectable medication to help prevent HIV infection, and how its effectiveness may be complicated by the cost and complexity of the US health care system.

Anti–SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021

Posted on by

JAMA
March 8, 2022, Vol 327, No. 10, Pages 897-1003
https://jamanetwork.com/journals/jama/currentissue

 

Anti–SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021
Caroline L. Behr, AB; Karen E. Joynt Maddox, MD, MPH; Ellen Meara, PhD; et al.
free access has active quiz
JAMA. 2022;327(10):980-983. doi:10.1001/jama.2022.1243
This study assesses how a limited supply of monoclonal antibody therapy was allocated to patients at highest risk of severe disease among a population of fee-for-service Medicare beneficiaries with a new COVID-19 diagnosis or confirmed exposure between November 2020 and August 2021.

Anti–SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021

Posted on by

JAMA
March 8, 2022, Vol 327, No. 10, Pages 897-1003
https://jamanetwork.com/journals/jama/currentissue

 

Anti–SARS-CoV-2 Monoclonal Antibody Distribution to High-risk Medicare Beneficiaries, 2020-2021
Caroline L. Behr, AB; Karen E. Joynt Maddox, MD, MPH; Ellen Meara, PhD; et al.
free access has active quiz
JAMA. 2022;327(10):980-983. doi:10.1001/jama.2022.1243
This study assesses how a limited supply of monoclonal antibody therapy was allocated to patients at highest risk of severe disease among a population of fee-for-service Medicare beneficiaries with a new COVID-19 diagnosis or confirmed exposure between November 2020 and August 2021.

Viewpoint
Long-Acting Cabotegravir for HIV PreventionIssues of Access, Cost, and Equity
Joshua M. Sharfstein, MD; Amy Killelea, JD; Derek Dangerfield, PhD
free access
JAMA. 2022;327(10):921-922. doi:10.1001/jama.2022.0420
This Viewpoint discusses the recent FDA approval of cabotegravir, the first injectable medication to help prevent HIV infection, and how its effectiveness may be complicated by the cost and complexity of the US health care system.

Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy

Posted on by

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

Original Investigation
Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy
Nir Kugelman, MD; Chen Nahshon, MD; Pninit Shaked-Mishan, PhD; et al.
free access has active quiz
JAMA Pediatr. 2022;176(3):290-295. doi:10.1001/jamapediatrics.2021.5683
This cohort study evaluates maternal and neonatal COVID-19 antibody levels at delivery after receipt of a messenger RNA (mRNA) COVID-19 vaccine during the second trimester of pregnancy.

What Parents Should Consider When Enrolling Children in Research

Posted on by

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

JAMA Pediatrics Patient Page
What Parents Should Consider When Enrolling Children in Research
Lindsay A. Thompson, MD, MS; Rebeccah Mercado, MS
free access
JAMA Pediatr. 2022;176(3):332. doi:10.1001/jamapediatrics.2021.6025
This Patient Page describes how parents may find out about different types of research studies that their child may enroll in and defines informed parental consent and assent.

Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries

Posted on by

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries
Jean B. Nachega, MD, PhD, MPH; Nadia A. Sam-Agudu, MD; Rhoderick N. Machekano, PhD, MPH; et al.
open access online only has active quiz
JAMA Pediatr. 2022;176(3):e216436. doi:10.1001/jamapediatrics.2021.6436
This cohort study assesses clinical outcomes and associated factors among children and adolescents hospitalized with COVID-19 in 6 sub-Saharan African countriesAMA Pediatrics Patient Page

Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US

Posted on by

JAMA Pediatrics
March 2022, Vol 176, No. 3, Pages 220-332
https://jamanetwork.com/journals/jamapediatrics/currentissue

 

Research Letter
Human Papillomavirus Vaccination and Trends in Cervical Cancer Incidence and Mortality in the US
Tara Tabibi, BA; Justin M. Barnes, MD, MS; Aneri Shah, BS; et al.
JAMA Pediatr. 2022;176(3):313-316. doi:10.1001/jamapediatrics.2021.4807
This cohort study examines the association of human papillomvirus vaccination with cervical cancer incidence and mortality rates in the US, comparing age groups understood to have differing levels of vaccination.

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis

Posted on by

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 12 Mar 2022)

 

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
Elizabeth F. Peacocke, Sonja L. Myhre, Hakan Safaralilo Foss, Unni Gopinathan
Research Article | published 11 Mar 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003944

Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 12 Mar 2022]

 

Research Article
Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France
Antoine Eliès, Claire Bonneau, Sophie Houzard, Roman Rouzier, Delphine Héquet
Research Article | published 11 Mar 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0264821

Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: A cross-sectional survey

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 12 Mar 2022]

 

Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: A cross-sectional survey
Tadesse Tolossa, Bizuneh Wakuma, Ebisa Turi, Diriba Mulisa, Diriba Ayala, Getahun Fetensa, Belayneh Mengist, Gebeyehu Abera, Emiru Merdassa Atomssa, Dejene Seyoum, Tesfaye Shibiru, Ayantu Getahun
Research Article | published 09 Mar 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0265061

Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 12 Mar 2022]

 

Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons
David Ortiz-Paredes, Olivia Varsaneux, James Worthington, Hyejin Park, Shannon E. MacDonald, Nicole E. Basta, Bertrand Lebouché, Joseph Cox, Shainoor J. Ismail, Nadine Kronfli
Research Article | published 09 Mar 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0264145

Real-time pandemic surveillance using hospital admissions and mobility data

Posted on by

PNAS – Proceedings of the National Academy of Sciences of the United States
February 15, 2022 | vol. 119 | no. 7
https://www.pnas.org/toc/pnas/119/7

 

Research Article February 1, 2022 Open Access
Real-time pandemic surveillance using hospital admissions and mobility data
Forecasting the burden of COVID-19 has been impeded by limitations in data, with case reporting biased by testing practices, death counts lagging far behind infections, and hospital census reflecting time-varying patient access, admission criteria, and …
Spencer J. Fox, Michael Lachmann,[…] Lauren Ancel Meyers

Intention to vaccinate children for COVID-19: A segmentation analysis among Medicaid parents in Florida

Posted on by

Preventive Medicine
Volume 156 March 2022
https://www.sciencedirect.com/journal/preventive-medicine/vol/156/suppl/C

 

Regular Articles
Research article Full text access
Intention to vaccinate children for COVID-19: A segmentation analysis among Medicaid parents in Florida
Matthew W. Kreuter, Rachel Garg, Alexis Marsh, Tess Thompson, … Amy McQueen
Article 106959

Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S): Evidence of Measurement Invariance Across Five Countries

Posted on by

Risk Management and Healthcare Policy
https://www.dovepress.com/risk-management-and-healthcare-policy-archive56
[Accessed 12 Mar 2022]

 

Original Research
Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S): Evidence of Measurement Invariance Across Five Countries
Chen IH, Wu PL, Yen CF, Ullah I, Shoib S, Zahid SU, Bashir A, Iqbal N, Addo FM, Adjaottor ES, Amankwaah GB, Ahorsu DK, Griffiths MD, Lin CY, Pakpour AH
Published Date: 10 March 2022

COVID-19 vaccination: The road ahead

Posted on by

Science
Volume 375| Issue 6585| 11 Mar 2022
https://www.science.org/toc/science/current

 

Reviews
COVID-19 vaccination: The road ahead
BY Daniel M. Altmann, Rosemary J. Boyton
10 Mar 2022: 1127-11
A diverse array of successful, first-generation SARS-CoV-2 vaccines have played a huge role in efforts to bring the COVID-19 pandemic under control, even though inequitable distribution still leaves many vulnerable. Additional challenges loom for the next …

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel

Posted on by

Science
Volume 375| Issue 6585| 11 Mar 2022
https://www.science.org/toc/science/current

 

Reports
Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
BY Ottavia Prunas. Et al.
27 Jan 2022: 1151-1154
Open Access
Vaccination reduced both the rate of infection with SARS-CoV-2 and household transmission in Israel.

Impact of meningococcal C conjugate vaccine on incidence of invasive meningococcal disease in an 18-year time series in Brazil and in distinct Brazilian regions

Posted on by

Tropical Medicine & International Health
Volume 27, Issue 3 Pages: i-iv, 217-336 March 2022
https://onlinelibrary.wiley.com/toc/13653156/current

 

RESEARCH ARTICLES
Impact of meningococcal C conjugate vaccine on incidence of invasive meningococcal disease in an 18-year time series in Brazil and in distinct Brazilian regions
Mariana C. Cruz, Paulo Camargos, Cristiana M. Nascimento-Carvalho
Pages: 280-289
First Published: 08 January 2022

Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines

Posted on by

Vaccine
Volume 40, Issue 8 Pages 1061-1190 (16 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/8

 

Research article Full text access
Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines
Qiuyan Liao, Benjamin J. Cowling, Jingyi Xiao, Jiehu Yuan, … Wendy Wing Tak Lam
Pages 1074-1081

‘I trust them because my mum trusts them’: Exploring the role of trust in HPV vaccination decision-making among adolescent girls and their mothers in France

Posted on by

Vaccine
Volume 40, Issue 8 Pages 1061-1190 (16 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/8

 

Research article Open access
‘I trust them because my mum trusts them’: Exploring the role of trust in HPV vaccination decision-making among adolescent girls and their mothers in France
E. Karafillakis, P. Peretti-Watel, P. Verger, T. Chantler, H.J. Larson
Pages 1090-1097

Factors associated with maternal tetanus vaccination in Myanmar: An analysis of demographic and health survey data

Posted on by

Vaccine
Volume 40, Issue 8 Pages 1061-1190 (16 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/8

 

Research article Abstract only
Factors associated with maternal tetanus vaccination in Myanmar: An analysis of demographic and health survey data
Zaw Myo Tun, Zau Ring, Clarence C. Tam
Pages 1135-1142

COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales

Posted on by

Vaccine
Volume 40, Issue 8 Pages 1061-1190 (16 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/8

 

Research article Open access
COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales
Stuart Bedston, Ashley Akbari, Christopher I. Jarvis, Emily Lowthian, … Ronan A. Lyons
Pages 1180-1189

Pre-Print Servers

Posted on by

Pre-Print Servers

 

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 12 Mar 2022]

[No new digest content identified]

 

medRxiv
https://www.medrxiv.org/content/about-medrxiv
medRxiv is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information. medRxiv is for the distribution of preprints – complete but unpublished manuscripts – that describe human health research conducted, analyzed, and interpreted according to scientific principles…

Immunogenicity and safety of a recombinant adenovirus type-5 COVID 19 vaccine in adults: data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
Vitalina Dzutseva, Dmitry Lioznov, Irina Amosova, Savely A Sheetikov, Ksenia V Zornikova, Yana Serdyuk, Grigory A Efimov, Mikhail Tsyferov, Mikhail Khmelevskii, Andrei Afansiev, Nadezdha Khomyakova, Dmitry Zubkov, Anton Tikhonov, Tao Zhu, Luis Barreto
medRxiv 2022.03.01.22271507; doi: https://doi.org/10.1101/2022.03.01.22271507

Real world performance of inactivated SARS-CoV-2 vaccine (CoronaVac) against infection, hospitalization and death due to COVID-19 in adult population in Indonesia
Anton Suryatma, Raras Anasi, Miko Hananto, Asep Hermawan, Ririn Ramadhany, Irene Lorinda Indalao, Agustiningsih Agustiningsih, Ely Hujjatul Fikriyah, Kristina Lumban Tobing, Teti Tejayanti, Rustika Rustika, Pandji Wibawa Dhewantara
medRxiv 2022.02.02.22270351; doi: https://doi.org/10.1101/2022.02.02.22270351

Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model study
Rebecca K. Borchering, Luke C. Mullany, Emily Howerton, Matteo Chinazzi, Claire P. Smith, Michelle Qin, Nicholas G. Reich, Lucie Contamin, John Levander, Jessica Kerr, J Espino, Harry Hochheiser, Kaitlin Rainwater-Lovett, Matt Kinsey, Kate Tallaksen, Shelby Wilson, Lauren Shin, Joseph C. Lemaitre, Juan Dent Hulse, Joshua Kaminsky, Elizabeth C. Lee, Javier Perez-Saez, Jessica T. Davis, Kunpeng Mu, Xinyue Xiong, Ana Pastore y Piontti, Alessandro Vespignani, Ajitesh Srivastava, Przemyslaw Porebski, Srinivasan Venkatramanan, Aniruddha Adiga, Bryan Lewis, Brian Klahn, Joseph Outten, Benjamin Hurt, Jiangzhuo Chen, Henning Mortveit, Amanda Wilson, Madhav Marathe, Stefan Hoops, Parantapa Bhattacharya, Dustin Machi, Shi Chen, Rajib Paul, Daniel Janies, Jean-Claude Thill, Marta Galanti, Teresa K. Yamana, Sen Pei, Jeffrey Shaman, Guido España, Sean Cavany, Sean Moore, Alex Perkins, Jessica M. Healy, Rachel B. Slayton, Michael A. Johansson, Matthew Biggerstaff, Katriona Shea, Shaun Truelove, Michael C. Runge, Cécile Viboud, Justin Lessler
medRxiv 2022.03.08.22271905; doi: https://doi.org/10.1101/2022.03.08.22271905

Community Engagement to support COVID-19 Vaccine Uptake: A living systematic review protocol
Brynne Gilmore, Nina Gerlach, Claudia Abreu Lopes, Alpha Ahmadou Diallo, Sanghita Bhattacharyya, Vergil de Claro, Rawlance Ndejjo, Elizabeth Nyamupachitu- Mago, Adalbert Tchetchia
medRxiv 2022.03.08.22272082; doi: https://doi.org/10.1101/2022.03.08.22272082

Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021
Nicole G. Morozov, Amiel A. Dror, Amani Daoud, Netanel Eisenbach, Edward Kaykov, Masad Barhoum, Tsvi Sheleg, Eyal Sela, Michael Edelstein
medRxiv 2022.03.03.22271793; doi: https://doi.org/10.1101/2022.03.03.22271793

Social capital, urbanization level, and COVID-19 vaccination uptake in the United States: A national level analysis
Shan Qiao, Zhenlong Li, Jiajia Zhang, Xiaowen Sun, Camryn Garrett, Xiaoming Li
medRxiv 2022.03.04.22271917; doi: https://doi.org/10.1101/2022.03.04.22271917

Responsiveness to risk explains large variation in COVID-19 mortality across countries
Tse Yang Lim, Hazhir Rahmandad
medRxiv 2020.12.11.20247924; doi: https://doi.org/10.1101/2020.12.11.20247924

Using Google Health Trends to investigate COVID-19 incidence in Africa
Alexander Fulk, Daniel Romero-Alvarez, Qays Abu-Saymeh, Jarron M. Saint Onge, A. Townsend Peterson, Folashade B. Agusto
medRxiv 2021.03.26.21254369; doi: https://doi.org/10.1101/2021.03.26.21254369

Wellcome Open Research [to 12 Mar 2022]
https://wellcomeopenresearch.org/browse/articles
[Accessed 12 Mar 2022]

Wellcome Open Research provides all Wellcome researchers with a place to rapidly publish any results they think are worth sharing. All articles benefit from rapid publication, transparent peer review and editorial guidance on making all source data openly available.

Open Letter metrics AWAITING PEER REVIEW
A PowerPack of SuperScientists: An innovative concept by African scientists to address gender bias and inequity in science [version 1; peer review: awaiting peer review]
Maphe Mthembu, Omolara Baiyegunhi, Yanga Mdleleni, Lerato Ndlovu, Hannah Keal, Kim Waddilove, Justin C. Yarrow, Victoria Kasprowicz, Thumbi Ndung’u, Emily B. Wong
Peer Reviewers Invited
Funders
African Academy of Sciences
New Partnership for Africa’s Development
Government of the United Kingdom
Wellcome
PUBLISHED 11 Mar 2022

Research Article metrics
Revised
Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust [version 2; peer review: 1 approved with reservations]
Hayley Colton, David Hodgson, Hailey Hornsby, Rebecca Brown, Joanne Mckenzie, Kirsty L. Bradley, Cameron James, Benjamin B. Lindsey, Sarah Birch, Louise Marsh, Steven Wood, Martin Bayley, Gary Dickson, David C. James, Martin J. Nicklin, Jon R. Sayers, Domen Zafred, Sarah L. Rowland-Jones, Goura Kudesia, Adam Kucharski, CMMID COVID-19 Working Group, Thomas C. Darton, Thushan I. de Silva, Paul J. Collini
Peer Reviewer Mo Yin
Funders
Wellcome Trust
The Danson Foundation
Sheffield Teaching Hospitals NHS Foundation Trust
LATEST VERSION PUBLISHED 10 Mar 2022

Review metrics AWAITING PEER REVIEW
Innovations in peer review in scholarly publishing: a meta-summary [version 1; peer review: awaiting peer review]
Helen Buckley Woods, Johanna Brumberg, Wolfgang Kaltenbrunner, Stephen Pinfield, Ludo Waltman
Peer Reviewers Invited
Funder
Wellcome Trust
PUBLISHED 09 Mar 2022

Research Article metrics AWAITING PEER REVIEW
Quantitative methods for group bibliotherapy research: a pilot study [version 1; peer review: awaiting peer review]
Emily T. Troscianko, Emily Holman, James Carney
Peer Reviewers Invited
Funders
Wellcome Trust
Balliol Interdisciplinary Institute
PUBLISHED 07 Mar 2022

Think Tanks

Posted on by

Think Tanks
 
 
Brookings
http://www.brookings.edu/
Accessed 12 Mar 2022
Order from Chaos
Taiwan’s people are not impressed with China’s “Zero COVID” status
Shelley Rigger, Lev Nachman, Chit Wai John Mok, and Nathan Kar Ming Chan
Friday, March 11, 2022

TechStream
China and Russia are joining forces to spread disinformation
David Bandurski
Friday, March 11, 2022
 
 
Center for Global Development [to 12 Mar 2022]
https://www.cgdev.org/
Accessed 12 Mar 2022
Last Week in the US International COVID-19 Response
March 8, 2022
In the global response to COVID-19, the Biden administration made news last week on several fronts. Here is a quick recap and some ideas for moving forward.
Jocilyn Estes, Julia Kaufman and Eleni Smitham
 
 
Chatham House [to 12 Mar 2022]
https://www.chathamhouse.org/
Accessed 12 Mar 2022
[No new digest content identified]

 
 
CSIS
https://www.csis.org/
Accessed 12 Mar 2022
Podcast Episode
Dr. Heidi Larson: “The nature of the security threat has changed”
March 11, 2022 | By Katherine E. Bliss, Heidi J. Larson

Transcript
Overcoming Gender-Related Barriers to Immunization Services
March 10, 2022

Report
North Korea’s Covid-19 Lockdown: Current Status and Road Ahead
March 9, 2022 | By Victor Cha, Katrin Fraser Katz, J. Stephen Morrison

 
 

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 12 Mar 2022
March 10, 2022 News Release
4 in 10 Workers – and 6 in 10 of Those with Low Incomes – Say They Missed Work During the Omicron Surge Due to COVID-19 Illness, Quarantine or Closure
The surge in COVID-19 cases triggered by the omicron variant led to widespread work disruptions, with about 4 in 10 workers (42%) – including 6 in 10 of those with lower incomes – saying they had to miss work at least once in the past three months because of a…
 
 
Rand [to 12 Mar 2022]
https://www.rand.org/pubs.html
Reports, Selected Journal Articles
[No new digest content identified]

Vaccines and Global Health: The Week in Review :: 5 March 2022

Posted on by

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version:  A pdf of the current issue is available here:

vaccines-and-global-health_the-week-in-review_05-march-2022Download

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

Ukraine

Posted on by

Ukraine

WHO – Ukraine Emergency
WHO is working closely with our offices in Ukraine and neighbouring countries, as well as partners to rapidly respond to the health emergency triggered by the conflict and to minimize disruptions to the delivery of critical healthcare services.
WHO continues to deliver much-needed support on urgent health needs. During the crisis, health must remain a priority pillar, with health workers being protected so they can continue to save lives and with health systems and facilities being protected so that they remain functional, safe and accessible to all who need essential medical services. It is imperative to ensure that life-saving medical supplies – including oxygen – reach those who need them.

Emergency in Ukraine – Situation Report 1
5 March 2022  | Emergency Situational Updates
[Excerpts]

Priority public health concerns
Conflict related trauma and injuries exacerbated by lack of access to health facilities by patients and health staff due to insecurity and lack of access to lifesaving medicine and supplies.
Excess morbidity and death from common illnesses due to disruption in services such as non-communicable diseases (cardiovascular, diabetes, cancer etc.) and acute maternal, newborn and child illnesses.
Spread of infectious diseases such as COVID-19, measles, polio, TB, HIV and diarrheal diseases due to widespread destruction of water and sanitation infrastructure, inadequate vaccination coverage, lack of access to medicines and medical care, safe water, adequate sanitation and hygiene as well as population movements and crowding.
Mental health and psychosocial health – due to significant stress due to acute conflict and two years of COVID-19.

…2.3. Epidemic prone and other infectious diseases
Recent outbreaks of polio and measles threaten the health of populations with suboptimal vaccination coverage (80% and 82% respectively in 2021), and the prevalence of HIV and tuberculosis, including multidrug resistant tuberculosis, are among the highest in Europe. Urgent actions are to re-start or continue preventive measures through vaccination and continued treatment for TB and HIV and to scale up surveillance, early detection and response systems for epidemic-prone diseases.
A polio outbreak (circulating vaccine-derived poliovirus type 2) was confirmed in the country in 2021, with two paralytic cases (detected in October and December 2021), and a total of 21 individuals in two oblasts (Rivne and Zakarpattya) who had positive isolation of cVDPV2 in stool specimens. As a result, a nationwide vaccination campaign targeting all under-vaccinated children (those having only zero or one dose) aged between 6 months and 6 years that began in February 2022. This campaign has been suspended because of the conflict, increasing the risk of further spread.
Over 240 000 weekly cases and 1300 deaths were reported for COVID-19 in the week 21-27 February. While this is a 43% decrease in cases compared to the previous week, testing rates have also declined sharply since the start of the conflict, with a likely significant undetected ongoing transmission. The ongoing high incidence levels of COVID-19 poses a significant risk of severe disease and death, particularly given the low vaccination coverage in at-risk population groups. Critical shortages of oxygen further impact on the ability to treat patients with severe COVID-19, and many other conditions. Beds occupied by COVID-19 patients were repurposed for trauma injuries and critical illnesses.

 

Emergency appeal – Ukraine and neighbouring countries
2 March 2022